A highly selective near infrared fluorescent probe for carboxylesterase 2 and its biological applications

Carboxylesterase 2 (CES 2) is a key enzyme in the activation of the prodrug irinotecan (CPT-11) in the treatment against colorectal cancer and also has some relationship with the side effect of CPT-11 in clinical applications. Herein, a near infrared (NIR) fluorescent probe ( DSAB ) has been designe...

Full description

Saved in:
Bibliographic Details
Published in:Journal of materials chemistry. B, Materials for biology and medicine Materials for biology and medicine, 2021-03, Vol.9 (1), p.2457-2461
Main Authors: Zhang, Xin-Yue, Liu, Tian-Tian, Liang, Jia-Hao, Tian, Xiang-Ge, Zhang, Bao-Jing, Huang, Hui-Lian, Ma, Xiao-Chi, Feng, Lei, Sun, Cheng-Peng
Format: Article
Language:English
Subjects:
Carboxylesterase
Colorectal carcinoma
Fluorescent indicators
Health services
Herbal medicine
High-throughput screening
Inhibitors
Irinotecan
Medical treatment
Selectivity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Carboxylesterase 2 (CES 2) is a key enzyme in the activation of the prodrug irinotecan (CPT-11) in the treatment against colorectal cancer and also has some relationship with the side effect of CPT-11 in clinical applications. Herein, a near infrared (NIR) fluorescent probe ( DSAB ) has been designed for CES 2 which possesses the advantages of prominent selectivity and high sensitivity, and DSAB has been successfully applied for the imaging of endogenous CES 2 in living cells. Moreover, a high-throughput screening method for CES 2 inhibitors has been established using DSAB and discovered four novel CES 2 inhibitors from various herbal medicines. These results fully demonstrated that DSAB is a promising molecular tool for the investigation of the biological functions of CES 2 in living systems and the discovery of novel CES 2 inhibitors for the treatment of CES 2 related physiological diseases. Carboxylesterase 2 (CES 2) is a key enzyme in the activation of the prodrug irinotecan (CPT-11) in the treatment against colorectal cancer and also has some relationship with the side effect of CPT-11 in clinical applications.
ISSN:2050-750X
2050-7518
DOI:10.1039/d0tb02673e